Mounjaro®
Starting from £179.99/mo
Start journey Learn moreThere is no single correct time of day to take Mounjaro. The Mounjaro SmPC does not specify morning or evening, so night-time dosing is not wrong — but side effects like nausea or disturbed sleep lead many people to settle on a different routine. The right time is the one that suits your body and that you can stick to every week. As a prescription-only medicine, your prescriber can help you work out what that looks like for you.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
One of the most common things people search before starting tirzepatide is whether night-time dosing unlocks better results or fewer side effects. The short answer is that no clinical trial has compared morning versus evening injections head-to-head, and the Mounjaro SmPC does not instruct patients to inject at any particular time of day. What the licence says (verified on the eMC SmPC) is once weekly, same day each week, any time, with or without food.
So the idea that evening is pharmacologically superior is a myth, and so is the reverse claim that morning is always better. Tirzepatide's half-life is approximately five days, which means the medicine is working steadily throughout the week regardless of when in the 24-hour cycle you inject. Timing affects your experience of side effects, not the medicine's effectiveness. That is the real question worth thinking through.
For a broader look at how tirzepatide works and what to expect across your first months of treatment, the tirzepatide overview on our site goes through the clinical background in plain language.
The case for evening dosing has a certain logic: nausea, which the NHS tirzepatide page lists as the most common side effect, tends to peak in the hours after injection. If you inject at bedtime and sleep through that window, you may wake up feeling fine. A number of people find this genuinely useful, particularly in the first few weeks at 2.5mg or after stepping up to a higher dose.
The case against is equally real. Some people report disrupted sleep, vivid dreams, or a vague restlessness when they inject in the evening. This is not listed as a common side effect in the SmPC, but it is mentioned often enough in clinical discussions that it is worth taking seriously. If you already have sleep difficulties, adding a new variable at bedtime is worth discussing with your prescriber before committing to it, and our page on whether you can take tirzepatide at night works through the considerations in detail.
A quick practical check: for a few weeks after any timing change, glance at how your sleep felt the night after each injection. One minute, no diary needed. Patterns usually emerge within three or four doses.
If you are weighing up the full range of timing options, our page on taking Mounjaro at night or in the morning sets the comparison out clearly.
Consistency is the factor that matters most. Because Mounjaro must be taken on the same day each week, people who attach their injection to an existing habit (a Sunday evening routine, a Monday morning ritual) tend to miss fewer doses. Missed or delayed doses are the most common clinical issue with weekly injectables, and the fix is almost always a more memorable anchor, not a different time of day.
A few practical notes worth knowing. Mounjaro pens should be stored in the fridge at 2–8°C until use; always check the Patient Information Leaflet for the exact window during which a pen removed from the fridge can be kept at room temperature, since the SmPC figure should be followed precisely rather than a number quoted online. Injection sites (abdomen, thigh or upper arm) should be rotated each week regardless of when you inject.
Our page on the best way to take Mounjaro covers technique, storage and rotation in more detail. For questions about choosing a day of the week that fits your schedule, picking the best day to take Mounjaro is a natural companion read.
If side effects at your current injection time are affecting your quality of life (persistent nausea through a working day, a regular run of poor nights) it is worth mentioning to your prescriber rather than simply switching and hoping for the best. They may suggest a different time, a different day, or an approach to managing nausea at the current dose before titrating upward, and our guide on when it is best to take Mounjaro is a helpful reference to read before that conversation. The MHRA Yellow Card scheme is also open to patients who want to report side effects formally, which helps regulators build a fuller picture of real-world experience.
Mounjaro is a prescription-only medicine, which means these decisions sit with a qualified clinician who knows your full health picture. At nume, every consultation is personally reviewed by a GPhC-registered Independent Prescriber (a real clinician, not automated software) on the same day you submit it. If you have questions about timing, nausea management or moving between doses, that is exactly the kind of thing our prescribers discuss as part of our clinical process. There are no hidden charges and no subscription, just one transparent price that covers everything, including 7-day aftercare access.
If you are still deciding whether Mounjaro fits your situation, our weight-loss treatments overview is a useful starting point before booking a consultation.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.